Steris PLC closed 15.99% below its 52-week high of $248.24, which the company achieved on September 13th.

Steris leaders told an investment firm they are "reluctant to expand capacity until the EO regulations are sorted out." ...

In a report released today, Michael Matson from Needham maintained a Hold rating on Steris (STE – Research Report). The company’s shares opened ...

In addition to scaling operations, Steris Healthcare will launch new medications and healthcare products aimed at addressing ...

Steris PLC closed 10.19% below its 52-week high of $248.24, which the company achieved on September 13th.

STERIS has a 12 month low of $197.82 and a 12 month high of $248.24. STERIS ( NYSE:STE – Get Free Report ) last announced its quarterly earnings results on Wednesday, February 5th.

A group of Waukegan area people impacted by the emission of ethylene oxide (EtO), a known carcinogen, from an industrial ...

Steris (STE) disclosed last night that its subsidiary, Isomedix Operations, entered into binding confidential term sheets with plaintiffs’ ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...